1. Market Research
  2. > Retrophin, LLC - Product Pipeline Review - 2013

Retrophin, LLC - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 26 pages

Retrophin, LLC - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Retrophin, LLC - Product Pipeline Review - 2013” provides data on the Retrophin, LLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Retrophin, LLC’s corporate website, SEC filings, investor presentations and featured press releases, both from Retrophin, LLC and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Retrophin, LLC - Brief Retrophin, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Retrophin, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Retrophin, LLC with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Retrophin, LLC’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Retrophin, LLC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Retrophin, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Retrophin, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Retrophin, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Retrophin, LLC and identify potential opportunities in those areas.

Table Of Contents

Retrophin, LLC - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Retrophin, LLC Snapshot 4
Retrophin, LLC Overview 4
Key Information 4
Key Facts 4
Retrophin, LLC - Research and Development Overview 5
Key Therapeutic Areas 5
Retrophin, LLC - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Retrophin, LLC - Pipeline Products Glance 9
Retrophin, LLC - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Retrophin, LLC - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Retrophin, LLC - Drug Profiles 11
RE-021 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
RE-001 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
RE-003 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
RE-024 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Retrophin, LLC - Pipeline Analysis 16
Retrophin, LLC - Pipeline Products by Therapeutic Class 16
Retrophin, LLC - Pipeline Products by Target 17
Retrophin, LLC - Pipeline Products by Route of Administration 18
Retrophin, LLC - Pipeline Products by Molecule Type 19
Retrophin, LLC - Pipeline Products by Mechanism of Action 20
Retrophin, LLC - Recent Pipeline Updates 21
Retrophin, LLC - Dormant Projects 23
Retrophin, LLC - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26



List of Tables

Retrophin, LLC, Key Information 4
Retrophin, LLC, Key Facts 4
Retrophin, LLC - Pipeline by Indication, 2013 6
Retrophin, LLC - Pipeline by Stage of Development, 2013 7
Retrophin, LLC - Monotherapy Products in Pipeline, 2013 8
Retrophin, LLC - Phase II, 2013 9
Retrophin, LLC - Preclinical, 2013 10
Retrophin, LLC - Pipeline by Therapeutic Class, 2013 16
Retrophin, LLC - Pipeline by Target, 2013 17
Retrophin, LLC - Pipeline by Route of Administration, 2013 18
Retrophin, LLC - Pipeline by Molecule Type, 2013 19
Retrophin, LLC - Pipeline Products by Mechanism of Action, 2013 20
Retrophin, LLC - Recent Pipeline Updates, 2013 21
Retrophin, LLC - Dormant Developmental Projects,2013 23



List of Figures

Retrophin, LLC - Pipeline by Top 10 Indication, 2013 6
Retrophin, LLC - Pipeline by Stage of Development, 2013 7
Retrophin, LLC - Monotherapy Products in Pipeline, 2013 8
Retrophin, LLC - Pipeline by Top 10 Therapeutic Class, 2013 16
Retrophin, LLC - Pipeline by Top 10 Target, 2013 17
Retrophin, LLC - Pipeline by Top 10 Molecule Type, 2013 19
Retrophin, LLC - Pipeline Products by Top 10 Mechanism of Action, 2013 20



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.